Literature DB >> 29673610

Low exertional inspiratory capacity is not related to dynamic inspiratory muscle weakness in heart failure.

Franciele Plachi1, Fernanda Machado Balzan1, Ricardo Gass1, Rui Gustavo Dorneles1, Reisi Zambiazi1, Danton Pereira da Silva1, Paulo R Sanches1, Nadine Oliveira Clausell1, Danilo C Berton2.   

Abstract

Reduction in inspiratory capacity (IC) during exercise has been reported in chronic heart failure (CHF). Since inspiratory muscle dysfunction may be present to a variable degree, the assumption that IC reduction during exercise represents an increase in end-expiratory lung volume must be made with caution. This interpretation is flawed if patients develop dynamic inspiratory muscle strength reduction, i.e., progressively lower esophageal (Pes) pressures as the IC maneuvers are repeated. Sixteen CHF patients and 9 age-matched controls performed an incremental exercise test with serial IC and respiratory pressure measurements. Regardless whether IC decreased or not with exercise (N = 4 and N = 12, respectively), Pes,IC remained stable. This was confirmed by similar Pes,sniff immediately upon exercise cessation (p > .05). No association was found between changes in IC and related Pes from rest to peak exercise. Owing to the lack of dynamic inspiratory muscle weakness, non-invasive indexes of lung mechanics can be reliably obtained from exercise IC in CHF.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dyspnea; Exercise test; Heart failure; Hyperinflation; Respiratory mechanics; Respiratory muscles

Mesh:

Year:  2018        PMID: 29673610     DOI: 10.1016/j.resp.2018.04.005

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  1 in total

1.  Pulmonology approach in the investigation of chronic unexplained dyspnea.

Authors:  Danilo Cortozi Berton; Nathalia Branco Schweitzer Mendes; Pedro Olivo-Neto; Igor Gorski Benedetto; Marcelo Basso Gazzana
Journal:  J Bras Pneumol       Date:  2021-02-08       Impact factor: 2.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.